PD-L1 SP142 Immunohistochemistry Test: Your Guide to Targeted Cancer Treatment
Facing a cancer diagnosis can feel overwhelming, but understanding your treatment options brings hope and clarity. The PD-L1 SP142 test is a powerful tool that helps determine if immunotherapy could be the right path for your cancer journey. At Oracle Genomics, we understand the anxiety that comes with waiting for answers, which is why we provide accurate, reliable results you can trust.
Understanding Your PD-L1 SP142 Test
This specialised test examines your tumour tissue to measure the PD-L1 protein levels. Think of PD-L1 as a “stop sign” that cancer cells sometimes use to hide from your immune system. When this protein is present in high amounts, it means your cancer might be particularly responsive to immunotherapy drugs that remove this “stop sign,” allowing your body’s natural defences to fight the cancer more effectively.
Our expert pathologists use advanced immunohistochemistry techniques to provide precise measurements of PD-L1 expression, giving your oncologist the detailed information needed to personalise your treatment plan.
Who Should Consider This Test?
This test is particularly important if you:
- Have been diagnosed with certain types of cancer, including lung cancer, bladder cancer, or other solid tumours
- Are exploring immunotherapy as a treatment option
- Want to understand if targeted treatments could be more effective than traditional chemotherapy
- Need clarity on the best next steps in your cancer treatment journey
- Are working with an oncologist to develop a personalised treatment plan
Many South African patients have found this test invaluable in making informed decisions about their cancer care.
Why This Test Matters for Your Health
Getting the right information at the right time can make all the difference in your cancer treatment. The PD-L1 SP142 test offers:
- Personalised Treatment Guidance: Helps determine if immunotherapy could work for your specific cancer
- Potential for Better Outcomes: Identifies patients who may respond well to targeted treatments
- Reduced Treatment Side Effects: May help avoid unnecessary chemotherapy if immunotherapy is suitable
- Peace of Mind: Provides clear, scientific data to support treatment decisions
- Time-Sensitive Information: Fast results mean quicker treatment decisions
Understanding Your Results
We know waiting for test results can be stressful. At Oracle Genomics, we provide clear, easy-to-understand reports that your oncologist will discuss with you. Your results will indicate the level of PD-L1 expression in your tumour, which helps determine:
- Whether immunotherapy is likely to be effective
- The potential benefits of specific immunotherapies
- How your cancer might respond to different treatment approaches
Remember, your results are just one piece of information that helps your healthcare team create the best possible treatment plan for you.
Transparent Pricing – Invest in Your Health
| Service | Regular Price | Special Price | Value |
|---|---|---|---|
| PD-L1 SP142 Immunohistochemistry Test | ZAR 3,850 | Potential savings on ineffective treatments |
Turnaround Times:
- Sample submission: Daily by 6 PM
- Report for tissue block: 5 days
- Report for tissue biopsy: 5 days
- Report for large complex tissue: 7 days
Why Trust Oracle Genomics?
We’re committed to providing South Africans with access to world-class diagnostic testing:
- Nationwide Coverage: Serving patients across South Africa, including Johannesburg, Cape Town, Durban, and Pretoria
- Expert Analysis: Our specialised pathologists have extensive experience in cancer biomarker testing
- Accuracy Guaranteed: We use validated immunohistochemistry methods for reliable results
- Patient-Focused: We understand the emotional journey of cancer diagnosis and treatment
- Quick Turnaround: Fast results mean you don’t have to wait long for critical information
Sample Requirements
To ensure accurate results, please provide:
- Tumour tissue in 10% formal-saline OR formalin-fixed paraffin-embedded block
- Ship at room temperature
- Include a copy of your histopathology report
- Provide biopsy site information and clinical history
Your healthcare provider will help coordinate sample collection and submission.
Take the Next Step in Your Cancer Journey
Don’t let uncertainty delay your treatment decisions. The PD-L1 SP142 test provides the clarity you need to move forward with confidence.
Limited Time Offer: Save ZAR 1,150 on this essential cancer biomarker test. Take action today to get the information you need for informed treatment decisions.
“Knowledge is power when facing cancer. The PD-L1 test gave us the confidence to choose the right treatment path.” – Oracle Genomics Patient
